What Happened

Myntra has closed a long-standing investigation by the Enforcement Directorate (ED) regarding Foreign Exchange Management Act (FEMA) violations. The company settled with the Reserve Bank of India (RBI) via a compounding fee of ₹2.88 Lakh.

The violations involved procedural failures: delayed filing of Annual Performance Reports (APRs) for ₹42.85 Cr in overseas investments and executing ₹3.03 Cr in financial commitments while those reports were pending. The ED granted a no-objection certificate, allowing the RBI to finalize the compounding order on April 20, 2026.

Why It Matters

For operators, this illustrates the distinction between procedural non-compliance and substantive policy breaches. The compounding route provided a clean exit from a potentially lengthy investigation for a nominal fee, demonstrating that regulatory authorities are increasingly prioritizing administrative efficiency over punitive litigation for minor, self-reported, or procedural oversights.

However, this closure remains distinct from the broader, more aggressive scrutiny surrounding the ₹1,654.4 Cr FDI violation case filed against the company in 2025. This indicates a bifurcated regulatory environment: standard operational filings are treated with administrative pragmatism, while core business model compliance—specifically FDI rules—remains a high-stakes, litigious battlefield for major platforms.

The Numbers

  • ₹2.88 Lakh: Compounding fee paid to settle the investigation.
  • ₹42.85 Cr: Value of overseas investments tied to the filing delay.
  • ₹3.03 Cr: Financial commitments made while APRs were pending.

What To Watch

  • FDI Scrutiny: Monitor the 2025 case involving ₹1,654.4 Cr, as the resolution of this minor FEMA issue does not signal a cooling of broader investigative interest in Myntra’s ownership structure.
  • Administrative Rigor: Ensure cross-border compliance teams are synchronized with finance; late APR filings are low-hanging fruit for auditors that can trigger wider, unwanted regulatory deep-dives.
  • Compounding Adoption: Expect more companies to leverage the compounding mechanism as the ED leans into this path to clear backlogs, but use it as a tool for resolution, not a substitute for strict compliance.